Skip to main content
 

Shared Decision Making and Value Based Cancer Care Research

Thursday, January 17, 2019

The United States health care system has been evolving at a rapid pace with attempts to control costs while also improving outcomes for patients. Cancer care is at the center of these debates with 15.5 million cancer survivors and per person treatment costs exceeding all other diseases. Policy and decision makers are shifting from a volume-based system to value-based care in an effort to ensure that patients are receiving high-quality care at the lowest possible price. Click here to learn more about our most recent published journal articles to delve deeper into our research into value-based care designs.

New court ruling has the potential to change the future of the Affordable Care Act

Friday, December 21, 2018

A new court ruling has the potential to change the future of the Affordable Care Act (ACA or Obamacare). While nothing is changing immediately, it’s important for all people, including cancer patients, survivors, and their loved ones to understand what this means for them.

Changes Proposed to Prescription Drug Commercials

Friday, December 14, 2018

In May of 2018, the Trump Administration committed to lowering the costs of prescription drugs and out-of-pocket spending for patients. One of the ways in which the Administration suggested meeting this goal was by changing the information available to consumers in television ads that market medications, which lead to a new rule that would require pharmaceutical companies to disclose the “list price” of drugs.

Adequate Health Care Options could be threatened by States New Waiver Authority

Wednesday, October 31, 2018

Recently the Centers for Medicare and Medicaid Services (CMS) released new guidance for the Affordable Care Act’s section 1332 waivers, expanding the power of 1332s and allowing states to use the waivers to adjust traditional compliance with ACA requirements.

New Transparency Laws Could Help Patients Reduce Out-of-Pocket Drug Spending

Thursday, October 18, 2018

President Trump recently signed two bills into law aimed at reducing patients’ out-of-pocket spending on prescription medications. The “Patient’s Right to Know Drug Prices Act” and the “Know the Lowest Price Act” address a practice known as “gag clauses.”

Open Enrollment: November 1st to December 15th

Tuesday, October 9, 2018

As the Midterm Election approaches and many prepare for the holiday season, it’s critical to remember that the open enrollment period to purchase health insurance coverage for 2019 is quickly approaching as well. This is the time to make sure that you and your loved ones have access to comprehensive, quality, and affordable coverage through the Health Insurance Marketplace.

Get Ready to Vote this November

Tuesday, September 25, 2018

November is quickly approaching, which means Election Day, Tuesday, November 6th, will be here before we know it. As we lead up to this day, the Cancer Support Community’s Cancer Policy Institute urges you to get involved and vote! Read our blog for important information about registration deadlines, voter resources, and more.

CMS Decides to Put Treatment Decisions in the Hands of Insurers

Tuesday, August 14, 2018

On August 7, the Centers for Medicare and Medicaid Services (CMS) issued guidance giving Medicare Advantage (MA) plans (private insurance plans approved by Medicare that cover hospital and medical expenses) the option of applying prior authorization and step therapy for physician-administered and other Medicare Part B drugs (effective January 1, 2019) stating that this policy change will lower costs, improve quality of life, and ensure that patients receive the most preferred treatment.

Short-Term, Limited Duration Plans will Harm Patient’s Access to Comprehensive Coverage

Thursday, August 9, 2018

On August 1, 2018, the Administration finalized another policy that will impact access to quality health insurance coverage by expanding the availability of short-term, limited duration (STLD) insurance plans that are not required to cover essential health benefits or pre-existing conditions.

Administration’s New Rule Could Put Patients’ Health Coverage at Risk

Monday, June 25, 2018

Back in January, the Trump Administration proposed a new rule that would expand the availability of Association Health Plans (AHPs) that are exempt from regulations like the 10 essential health benefits (EHBs) set by the Patient Protection and Affordable Care Act (ACA or Obamacare). This week, the Trump Administration released a finalized policy to allow loosely affiliated business to band together as AHPs and offer plans that are not held to many important ACA consumer protections.

Pages

Authors